Andrew Buckler, M.S.
Andrew Buckler comes to Elucid Bioimaging with 30 years of industry R&D experience spanning imaging science, medical devices, and molecular medicine. He founded Elucid’s predecessor company BBMSC and co-founded vascuVis. with Philips, Agilent, HP, Siemens, and Eastman Kodak. Mr. Buckler has developed a number of quantitative imaging products, including a program that netted $100M new revenue in its first year, with a life cycle > 7 years and with spin offs touching all parts of a $1B annual imaging business, and holds 9 patents. He is also the originator of an in-vivo imaging hardware and software molecular medicine product for research applications in disease management and drug discovery. Mr. Buckler has served as Program Director for the Quantitative Imaging Biomarker Alliance (QIBA) since its inception, is presently a scientific advisor to the Foundation for the National Institutes of Health (FNIH) for regulatory decision making in clinical trials, and has served as Subject Matter Expert in imaging for both radiology and pathology informatics to the NCI, and Principal Investigator (PI) for grant programs from NSF in computer-aided prognostics and from NIST for the pursuit of informatics services for statistically valid and clinically meaningful development and performance assessment of quantitative imaging biomarkers. Mr. Buckler holds a certificate in “Leading Science-Based Enterprises” from Harvard Business School, an MSCS from the University of Rochester, and a BSEE from Lehigh University.